TMPRSS2:ERG fusion gene and androgen-ablation therapy in prostate cancer

Arch Pathol Lab Med. 2010 Jul;134(7):964-5; author reply 965. doi: 10.5858/2009-0499-LE.1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Gene Expression
  • Humans
  • Male
  • Oncogene Proteins, Fusion / genetics*
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / genetics*

Substances

  • Androgen Antagonists
  • Oncogene Proteins, Fusion
  • TMPRSS2-ERG fusion protein, human